Long‐term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin: a prespecified analysis from the randomized, phase III SYNERGY II study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long‐term treatment of older patients with overactive bladder using a combination of mirabegron and solifenacin: a prespecified analysis from the randomized, phase III SYNERGY II study

Published:2019-01-15 Issue:2 Volume:38 Page:779-792
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourology and Urodynamics

Author:

Mueller Elizabeth R.¹,van Maanen Rob²,Chapple Christopher³,Abrams Paul⁴,Herschorn Sender⁵,Robinson Dudley⁶,Stoelzel Matthias²,Yoon Sang J.⁷,Al‐Shukri Salman⁸,Rechberger Tomasz⁹,Gratzke Christian¹⁰

Affiliation:

1. Loyola University Chicago Stritch School of MedicineMaywoodIllinois

2. Astellas Pharma Global DevelopmentLeidenThe Netherlands

3. Royal Hallamshire HospitalSheffield Teaching Hospitals NHS Foundation TrustSheffieldUK

4. Bristol Urological InstituteSouthmead HospitalBristolUK

5. University of TorontoSunnybrook Health Sciences CentreTorontoOntarioCanada

6. King's College HospitalLondonUK

7. Gachon University Gil Medical CenterGachon University School of MedicineIncheonSouth Korea

8. Pavlov First Saint Petersburg State Medical UniversitySaint PetersburgRussia

9. Medical University of LublinLublinPoland

10. University of MunichMunichGermany

Funder

Astellas Pharma Europe

Astellas Pharma Global Development

Publisher

Wiley

Subject

Urology,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/nau.23919

Reference25 articles.

1. The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society

2. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

3. A Contemporary Assessment of Nocturia: Definition, Epidemiology, Pathophysiology, and Management—a Systematic Review and Meta-analysis

4. The coming acceleration of global population ageing

5. The aging lower urinary tract: a comparative urodynamic study of men and women

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mirabegron 50 mg once daily, long-term treatment maximizes benefit in middle-aged and older people with overactive bladder syndrome: a systematic review and meta-analysis of nine phase II/III, randomized, double-blind, parallel-design, placebo-controlled, multicenter, and multinational trials;Frontiers in Surgery;2024-08-26

2. Cost-Utility Analysis of Mirabegron Compared to Solifenacin in the Treatment of Overactive Bladder (OAB) in Iran;Iranian Journal of Pharmaceutical Research;2023-11-08

3. Current optimal pharmacologic therapies for overactive bladder;Expert Opinion on Pharmacotherapy;2023-10-05

4. Use of Fermented Red Clover Isoflavones in the Treatment of Overactive Bladder in Postmenopausal Women: A Randomized, Double-Blinded, Placebo-Controlled Trial;Nutrients;2023-09-27

5. Study of mirabegron and solifenacin in the improvement of catheter-related bladder discomfort in patients undergoing transurethral resection: A case–control study;Medicine;2022-12-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3